The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I

Creeping Acquisition Near ThresholdOwnership Changes View source PDF

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.8%1-day move

₹2010.00

prior close

₹2008.50

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.2-0.4-0.6-0.8-2.3+0.7+0.5+0.3+0.9+15.6+13.7+16.2+50.7

Up moveDown movePending

AI summary

ChrysCapital Associates LLP, acting as Investment Manager to Clarus Trust, filed a disclosure on behalf of Clarus Capital I (an AIF scheme) and its Person Acting in Concert (PAC) ClearEdge LLC. The acquirer purchased 1,45,113 equity shares (0.88%) on April 17, 2026, through open market. Before this acquisition, their combined holding was 7,49,734 shares (4.53%). After the acquisition, their holding increased to 8,94,847 shares (5.41%) of RPG Life Sciences Ltd. The company has a total equity share capital of Rs. 13,23,12,120 comprising 1,65,39,015 equity shares of Rs. 8/- each. The acquirer explicitly stated they do not belong to the Promoter/Promoter group.

Likely market impact

The crossing of the 5% threshold by an institutional investor (AIF) may signal increasing institutional confidence in the company. However, the small acquisition size (0.88%) suggests a measured approach rather than a takeover attempt.